Shire buys into regenerative medicine with Pervasis purchase

Article Date: 13/04/2012 10:00
Shire buys into regenerative medicine with Pervasis purchase

Vacancy Search

Quick job search

Advanced Search

Latest News

BMA publishes pre-election, four-step manifesto

BMA publishes pre-election, four-step manifesto

EU OKs Gardasil update on long-term HPV protection

EU OKs Gardasil update on long-term HPV protection

Gilead signs over hep C drugs to Indian pharmas

Gilead signs over hep C drugs to Indian pharmas

Roche starts Phase III trials of eye drug lampalizumab

Roche starts Phase III trials of eye drug lampalizumab

Germany tops global patient table for access to medicines

Germany tops global patient table for access to medicines

FDA gives green light to Baxter's Hyqvia

FDA gives green light to Baxter's Hyqvia

Dompe eyes ophthalmology market to drive growth

Dompe eyes ophthalmology market to drive growth

Fury at EU Commission pharma policy move

Fury at EU Commission pharma policy move

UK project into watch-size sensors for progressive MS

UK project into watch-size sensors for progressive MS

Offering prizes for low-return drugs a 'flawed concept', says Prof Jones

Offering prizes for low-return drugs a 'flawed concept', says Prof Jones
more news